article thumbnail

Covance, LabCorp’s Drug Development Business, Acclaimed by Frost & Sullivan for Its Unmatched Breadth of Services to Support Clinical Trials

Frost & Sullivan

Based on its recent analysis of the global contract research organization (CRO) market, Frost & Sullivan recognizes LabCorp’s drug development business, Covance, with the 2020 Global CRO Company of the Year Award.

article thumbnail

Top Drug Development Consulting Firms, Companies, Services, & Consultants

Jake Jorgovan

Novotech Novotech is a global full-service clinical Contract Research Organization (CRO) specializing in drug development consulting for biotech and pharmaceutical companies.

Biopharma 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novotech Awarded by Frost & Sullivan for Global Biotech Clinical Trials Excellence in APAC

Frost & Sullivan

SAN ANTONIO – January 30, 2022 – Frost & Sullivan recently analyzed the Asia-Pacific contract research organization industry and, based on its findings, recognizes Novotech with the 2022 Asia-Pacific Contract Research Organization Company of the Year Award.

Biotech 52
article thumbnail

George Clinical Applauded by Frost & Sullivan for Its Competitive Differentiation and Leadership in Strategy Execution in the Asia Pacific region

Frost & Sullivan

4 th May 2023 – Frost & Sullivan studied the contract research organization industry and, based on its findings, recognizes George Clinical with the 2023 Asia-Pacific Competitive Strategy Leadership Award. SAN ANTONIO, TX. –

article thumbnail

Is your retail health growth strategy aligning with the evolving needs of your customers?

Frost & Sullivan

This shift is benefiting pharmaceutical companies and contract research organizations (CROs) by facilitating decentralized trials, simplifying patient recruitment and retention, and reducing the number of phase 3 clinical sites. Central contracts with retailers are providing convenient access to numerous trial locations.

Retail 52
article thumbnail

Is your retail health growth strategy aligning with the evolving needs of your customers?

Frost & Sullivan

This shift is benefiting pharmaceutical companies and contract research organizations (CROs) by facilitating decentralized trials, simplifying patient recruitment and retention, and reducing the number of phase 3 clinical sites. Central contracts with retailers are providing convenient access to numerous trial locations.

Retail 52
article thumbnail

Frost & Sullivan Awards Avance Clinical for Global Biotech CRO Excellence, Highlighting Agility, Responsiveness, Customer Value, and Proven Ability to Expedite Quality Clinical Programs

Frost & Sullivan

27 th August 2024 – Frost & Sullivan recently assessed the biotech contract research organization (CRO) industry and, based on its results, recognizes Avance Clinical with the 2024 Global Customer Value Leadership Award. SAN ANTONIO, TX. –

Biotech 52